Results 281 to 290 of about 1,610,408 (351)

Novel mutation associated with non‐compaction ventricular myocardium: A case report

open access: yes
ESC Heart Failure, EarlyView.
Yan Li   +4 more
wiley   +1 more source

Long‐term prognosis of pure and impure tachycardiomyopathy

open access: yesESC Heart Failure, EarlyView.
Abstract Background and aims Tachycardia‐induced cardiomyopathy (TCM) is a reversible form of heart failure (HF) driven by arrhythmias, often atrial fibrillation (AF). While reversible, TCM's long‐term prognosis remains unclear, especially in comparison to HF with reduced ejection fraction (HFrEF).
Giulia Stronati   +11 more
wiley   +1 more source

Lead choice in cardiac implantable electronic devices: an Italian survey promoted by AIAC (Italian Association of Arrhythmias and Cardiac Pacing)

open access: gold, 2019
Matteo Ziacchi   +12 more
openalex   +1 more source

The Impact of Quality of Life on Cardiac Arrhythmias: A Clinical, Demographic, and AI-Assisted Statistical Investigation. [PDF]

open access: yesDiagnostics (Basel)
Nechita LC   +6 more
europepmc   +1 more source

Haemodynamic effects of istaroxime in SCAI stage B HF‐related cardiogenic shock: Insights from the SEISMiC trial

open access: yesESC Heart Failure, EarlyView.
Among patients with ADHF‐related SCAI stage B CS enrolled in SEISMiC, istaroxime at doses up to 1.0 μg/kg/min for up to 60 h was associated with sustained improvements in aortic pulsatility index and LV stroke work index, and with increase of PA compliance and reduction in PA elastance at 48 h.
Matteo Pagnesi   +21 more
wiley   +1 more source

Concise Guidelines of the European Cardiac Arrhythmias Society (ECAS) on "Catheter Ablation of Atrial Fibrillation". [PDF]

open access: yesJ Cardiovasc Electrophysiol
Cappato R   +13 more
europepmc   +1 more source

Minimization or withdrawal of oral pharmacotherapy in chronic heart failure patients with improved myocardial function: A systematic review

open access: yesEuropean Journal of Heart Failure, EarlyView.
This systematic review included seven studies that reported the outcomes of minimization or withdrawal of oral pharmacotherapy in chronic heart failure (HF) patients with improved myocardial function. There is a dearth of existing evidence, which supports only loop diuretic withdrawal and possibly carvedilol monotherapy.
Yuxiang Luo   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy